Crunching the numbers for BDX... Refresh in a moment for the full analysis.
BECTON DICKINSON & CO (BDX)
Healthcare
Deep Overvalued
mixed
$156.03
Updated: 2026-04-09
Financial Strength
55
Mixed
Capital Allocation
55
Mixed
Fair Value
$0.0
Sector Rank
#10
of 18
Key Findings
+
Historically cheap — EV/EBITDA in bottom 25% of its 5-year range
−
High leverage — net debt/EBITDA between 3× and 5×
See the full analysis
Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.
Create Free Account
Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.